title: Predicting risk of progressive multifocal leukoencephalopathy from natalizumab.
authors.forename: Allan H
authors.initials: AH
authors.lastname: Ropper
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000914:Antibodies, Viral / Q000097:blood*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007577:JC Virus / Q000276:immunology*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced*; D008297:Male; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D000069442:Natalizumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000914:Antibodies, Viral; D007166:Immunosuppressive Agents; D000069442:Natalizumab